Effect of Amorphophallus Konjac oligosaccharides on STZ-induced diabetes model of isolated islets

Life Sciences

Volumn 72, Issue 6, 2002, Pages 711-719

  Lu, Xiu Ju ^a   Chen, Xiu Min ^a   Fu, De Xian ^a   Cong, Wei ^a   Ouyang, Fan ^a  

^a INSTITUTE OF PROCESS ENGINEERING   (China)

Author keywords

Diabetes model; Konjac oligosaccharide; Nitric oxide; Streptozotocin

Indexed keywords

CARBOHYDRATE; FREE RADICAL; INSULIN; MANNOSE; NITRIC OXIDE; OLIGOSACCHARIDE; SCAVENGER; STREPTOZOCIN;

AMORPHOPHALLUS KONJAC; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MODEL; HYPOGLYCEMIA; INSULIN RELEASE; ISOLATION PROCEDURE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PANCREAS ISLET; PLANT; PLANT ROOT; REGULATORY MECHANISM; RISK; STREPTOZOCIN DIABETES; STRUCTURE ANALYSIS;

AMORPHOPHALLUS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; NITRIC OXIDE; OLIGOSACCHARIDES; PLANT ROOTS; STREPTOZOCIN;

AMORPHOPHALLUS; AMORPHOPHALLUS KONJAC;

EID: 0037184692     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02303-2     Document Type: Article

References (27)

1. Oblerley L.W. Free radicals and diabetes. Free Radical Biological Medicine. 5:1988;113-124.
2. Abdella N., Al Awadi F., Salman A., Armstrong D. Thiobarbituric acid test as a measure of lipid peroxidation in Arab patients with NIDDM. Diabetes Research. 15:1990;173-177.
3. Strain J.J. Disturbances of micronutrient and antioxidant status in diabetes. Proceeding of Nutrition Society. 50:1991;591-604.
4. Jain S.K., Levine S.N., Duett J., Hollier B. Reduced vitamin E and increased lipofuscin products in erythrocytes of diabetic rats. Diabetes. 40:1991;1241-1244.
5. Nourooz-Zadeh J., Tajaddini-sarmadi J., McCarthy S., Betteridge D.J., Wolff S.P. Evaluated levels of authentic plasma hydroperoxides in NIDDM. Diabetes. 44:1995;1054-1058.
6. Galvan A.Q., Muscelli E., Catalano C., Natali A., Sanna G., Masoni A., Bernardini B., Barsacchi R., Ferrannini E. Insulin decreases circulating vitamin E levels in humans. Metabolism. 45:1996;998-1003.
7. Paolisso G., Giugliano D. Oxidative stress and insulin action: Is there a relationship? Diabetologia. 39:1996;357-363.
8. Santini S.A., Marra G., Giardina B., Cotroneo P., Mordente A., Martorana G.E., Manto A., Ghirlanda G. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes. 46:1997;1853-1858.
9. Thomas G., Ramwell P.W. Streptozotocin: a nitric oxide-carrying molecule and its effects on vasodiation. European Journal of Pharmaceutical. 261:1989;279-280.
10. Shafrir E. Animal models of non-insulin-dependent diabetes. Diabetes Metabolism Review. 8:1992;179-208.
11. Kim S.Y., Kang S.K., Lee D.G., Park Y.G., Lee Y.C., Chung J.C., Kim C.H. Effect of Jindangwan on streptozotocin-induced diabetes. Life Sciences. 67:2000;1251-1263.
12. Ai Z.M., Xu L. Research progress of chemical components of Traditional Chinese Drugs. Chinese Traditional and Herbal Drugs. 30(6):1999;468-470.
13. Wang X.G., Zhao J., Du Q.P. Effects of compound Konjac granules on plasma glucose level of type 2 diabetes subjects. Journal of Jining Medical College (Chinese). 18(3):1995;29-30.
14. Mao C.P., Gu Z.G. Hypoglycemic effect of puncturevine caltrap (Amorphophallus Konjac). The Chinese Pharmaceutical Association. 16(6):1999;14-15.
15. Peng S.S., Zhang M.Y., Zhang Y.Z. Effects of Amorphophallus Konjac on the senescence of cranial nerve cells, liver cell and cardiac muscle cells in rats. Acta Nutrimenta Sinica. 16(3):1994;280-284.
16. Gu Y.D., Shi J.X., Hu Z.Y. Anti-senescence effect of Amorphophallus Konjac polysaccharide. Chinese Traditional and Herbal Drugs. 2(2):1999;127-128.
17. Luo D.Y., Li Y.Q. Inhibition effects of Konjac on genesis of MNNG-induced lung tumor in mice. Chinese Journal of Oncology. 14(1):1992;48-50.
18. Ramanadham S., Bohrer A., Mueller M., Jett P., Gross R., Turk J. Mass spectrometric identification and quantitation of Arachidonate-containing phospholipids in pancreatic islets: prominence of plasmenylethanolamine molecular species. Biochemistry. 32:1993;5339-5351.
19. Ridnour L.A., Sim J.E., Hayward M.A., Wink D.A., Martin S.M., Buettner G.R., Spitz D.R. A spectrophotometric method for the direct detection and quantitation of nitric oxide, nitrite and nitrate in cell culture media. Analytical Biochemistry. 281(2):2000;223-229.
20. Starr J.I., Horwitz D.L., Rubenstein A.H., Mako M.E. Insulin, Proinsulin and C-peptide. Jaffe B.M., Behrman H.R. Methods of Hormone Radioimmunoassay. 1978;613-633 Academic Press Inc. London.
21. Moncada S., Palmer R., Higgs E. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmaceutical Review. 43(2):1991;109-142.
22. Beckman J.S., Chen J., Ischiropoulos H., Grow J.P. Oxidative chemistry of peroxinitrite. Methods in Enzymology. 233:1994;229-240.
23. Gandy S.E., Galbrath R.A., Crouch R.K., Buse M.G., Galbraich G.M. Superoxide dismutase in human islets of Langerhans. The New England Journal of Medicine. 304:1981;1547-1553.
24. Corbett J.A., Kwon G., McDaniel M.L. Role of nitric oxide in β-cell destruction. Diabetes. 44:1995;39-46.
25. Opara E.C., Abdel-Rahman E., Soliman S., Kamel W.A., Souba S., Lowe J.E., Abdel-Aleem S. Depletion of total antioxidant capacity in type 2 diabetes. Metabolism. 48(11):1999;1414-1417.
26. Rehman A., Nourooz-Zadeh J., Moller W., Tritschler H., Halliwell B. Increased oxidative damage to all DNA bases in patients with type 2 diabetes mellitus. FEBS letters. 448:1999;120-122.
27. Zykova S., Jenssen T., Berdal M., Olsen R., Myklebust R., Seljelid R. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type 2-like db/db mice. Diabetes. 49:2000;1451-1458.